April 21, 2026
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreMay 18, 2026
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreApril 21, 2026
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreApril 21, 2026
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreJanuary 22, 2026
According to our insight calculates, the PRP and stem cell alopecia treatment market was valued at approximately USD 489.27 million in 2025 and is projected to grow from USD 515.93 million in 2026 to around USD 831.79 million by 2035, registering a CAGR of 5.45% during the forecast period....
January 21, 2026
Projections indicate that, the global anti-obesity drugs market will increase from USD 9.11 billion in 2025 to USD 99.74 billion by 2035, experiencing a CAGR of 27.04% over the next 10 years. In 2024, North America led the anti-obesity drugs market, with Asia Pacific set for the fastest growth. Prescription drugs dominated, while OTC drugs are pois...
January 21, 2026
Based on our market forecasts, the hemophilia inhibitors sector will expand from USD 16.43 billion in 2025 to USD 29.54 billion by 2035, experiencing a CAGR of 6.04%....
January 21, 2026
According to market projections, the polycystic ovary syndrome treatment sector is expected to grow from USD 5.15 billion in 2025 to USD 9.72 billion by 2035, reflecting a CAGR of 6.56%. The primary need for PCOS treatment is due to the rising concerns related to infertility, metabolic issues, pregnancy complications, mental health disorders, etc. ...
January 21, 2026
Based on market forecasts, the Europe behavioral health market, projected at USD 36.82 billion in 2025, is expected to reach USD 67.12 billion by 2035, growing at a CAGR of 6.19% over the forecast period. The Europe behavioral health market is expanding due to growing mental health awareness....
January 20, 2026
The GLP-1 receptor agonist market size is calculated at $62.86 bn in 2025 is to hit $315.33 bn by 2035. GLP-1 receptor agonists are peptide drugs that mimic the GLP-1 hormone to lower blood glucose and aid weight loss. With rising diabetes and obesity rates, the market is growing. Recent developments include Eli Lilly's Zepbound, Novo Nordisk's par...
January 20, 2026
Projections indicate the global chemotherapy market will increase from USD 10.29 billion in 2025 to USD 21.33 billion by 2035, experiencing a CAGR of 7.56% over the next 10 years. In 2024, North America led the global chemotherapy market with a 45% share. The Asia Pacific region is expected to grow the fastest. Alkylating agents dominated, while le...
January 20, 2026
Our projections indicate that, the Ayurveda market was valued at USD 20.45 billion in 2025 and is estimated to reach USD 24.49 billion in 2026, expanding significantly to USD 124.01 billion by 2035, registering a strong CAGR of 19.75% during 2026 to 2035....
January 19, 2026
According to forecasts, the global asthma and COPD drugs market will grow to USD 70.27 billion by 2035, with an expected CAGR of 5.01%. In 2024, King's College London showed that benralizumab can reduce hospitalizations in severe asthma and treat asthma and COPD. Boehringer Ingelheim launched a $35/month inhaler program for uninsured or high-copay ...
January 19, 2026
According to market projections, the cell therapy sector is expected to grow from USD 7.21 billion in 2025 to USD 55.72 billion by 2035, reflecting a CAGR of 22.69%. The focus on developing therapeutics for rare diseases is driving the market growth....
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
